Search

everythinglearnresearchcommunity

for

Search:↓

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Autologous Regenerative Therapy may improve hair restoration by using stem cells from fat.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Trichoscopy effectively diagnoses temporal triangular alopecia in children.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

A hair test shows promise for early mood disorder diagnosis.

Traumatic stress and alexithymia may contribute to alopecia areata.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Combining PRS with TAFR is promising for treating complex fistulas, with most patients achieving long-term healing.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

Dutasteride is a safe and effective treatment for hair loss.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Dutasteride is highly effective for hair loss treatment in Korea, with more side effects than finasteride.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

The FDA rejected a testosterone drug again due to safety concerns.

ALDOA levels drop in hair cells during hair loss.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Tofacitinib helped regrow hair in a teen with a unique pattern of alopecia areata.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.